| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,634 |
3,888 |
$281K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
779 |
678 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,697 |
1,476 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,601 |
1,479 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
199 |
191 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
383 |
363 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
293 |
264 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
72 |
62 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,186 |
1,088 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$909.59 |
| 85651 |
|
332 |
321 |
$829.00 |
| 81003 |
|
78 |
73 |
$138.68 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
30 |
28 |
$32.09 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14 |
13 |
$17.28 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
274 |
228 |
$0.00 |
| 3074F |
|
145 |
125 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
739 |
638 |
$0.00 |
| 3079F |
|
16 |
13 |
$0.00 |
| G8477 |
Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg |
351 |
307 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
497 |
414 |
$0.00 |
| 3078F |
|
49 |
42 |
$0.00 |
| 90756 |
|
13 |
13 |
$0.00 |